Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
Total Assignments:
6
|
Patent #:
|
|
Issue Dt:
|
11/06/2018
|
Application #:
|
15516115
|
Filing Dt:
|
03/31/2017
|
Publication #:
|
|
Pub Dt:
|
10/26/2017
| | | | |
Inventors:
|
Andrew BUCHANAN, Peter CARIUK, Clare BALENDRAN, Fumin CHANG, Lewis H. ROMER et al
|
Title:
|
ANTIBODIES SPECIFIC FOR LOX1 AND USE IN TREATMENT OF CARDIOVASCULAR DISORDERS
|
|
Assignment:
1
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
MILSTEIN BUILDING |
GRANTA PARK |
CAMBRIDGE, UNITED KINGDOM CB216GH |
|
|
|
MEDIMMUNE ASTRAZENCA |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
2
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
SE-151 85 |
SODERTALJE, SWEDEN |
|
|
|
MEDIMMUNE ASTRAZENECA |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
3
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
MILSTEIN BUILDING |
GRANTA PARK |
CAMBRIDGE, UNITED KINGDOM CB216GH |
|
|
|
MEDIMMUNE ASTRAZENECA |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
4
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
3400 N. CHARLES STREET |
BALTIMORE, MARYLAND 21218 |
|
|
|
MEDIMMUNE ASTRAZENECA |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
5
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
ONE MEDIMMUNE WAY |
GAITHERSBURG, MARYLAND 20878 |
|
|
|
MEDIMME ASTRAZENECA |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
6
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
MILSTEIN BUILDING |
GRANTA PARK |
CAMBRIDGE, UNITED KINGDOM CB216GH |
|
|
|
MEDIMMUNE ASTRAZENECA |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Search Results as of:
06/21/2024 09:45 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|